Lv4
500 积分 2024-11-21 加入
Process Development for the First GMP Synthesis of SGD-9501-TFA, Part 1: Synthesis of Two Oligopeptide Fragments
14小时前
已完结
From Efficiency to Yield: Exploring Recent Advances in CHO Cell Line Development for Monoclonal Antibodies
7天前
已完结
Overview of antibody-drug conjugates nonclinical and clinical toxicities and related contributing factors
10天前
已完结
Preclinical studies of BB-1701, a HER2-targeting eribulin-containing ADC with potent bystander effect and ICD activity
10天前
已完结
Overview of antibody-drug conjugates nonclinical and clinical toxicities and related contributing factors
11天前
已完结
Reforming solid tumor treatment: the emerging potential of smaller format antibody-drug conjugate
11天前
已完结
Antibody–Drug Conjugates in Cancer and Beyond: Progress, Promise, and Perspectives
11天前
已完结
Patient-centric Comparability Assessment of Biopharmaceuticals
25天前
已完结
Mechanism of antibody reduction in cell culture production processes
1个月前
已完结
Risk Evaluation of N-Nitrosamines in Drug-Linker Intermediates Used To Generate Antibody–Drug Conjugates
1个月前
已完结
皖公网安备34019202002308
